Going circular: history, present, and future of circRNAs in cancer

Giuseppina Pisignano1, David C Michael2, Tanvi H Visal3,4

  • 1Department of Life Sciences, University of Bath, Claverton Down, Bath, BA2 7AY, UK. gp529@bath.ac.uk.

Oncogene
|August 16, 2023
PubMed

Insights

Circular RNAs (circRNAs) are stable RNA molecules regulating gene expression. Despite challenges in detection and function elucidation, their potential as cancer biomarkers and therapeutic targets is significant.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Thousands of circular RNAs (circRNAs), abundant and conserved single-stranded RNA molecules, have been identified.
  • CircRNAs regulate gene expression transcriptionally and post-transcriptionally, with distinct tissue- and development-specific patterns.
  • They are implicated in various normal and disease conditions, including cancer pathogenesis.

Purpose of the Study:

  • To review current knowledge of circRNA biogenesis and function.
  • To explore the involvement of circRNAs in tumorigenesis.
  • To discuss the potential utility of circRNAs in cancer-targeted therapy.

Main Methods:

  • Literature review of circRNA research.
  • Analysis of circRNA biogenesis and regulatory mechanisms.
  • Evaluation of circRNAs as diagnostic and prognostic biomarkers in cancer.

Main Results:

  • CircRNAs are stable and resistant to ribonucleases, making them promising biomarkers.
  • Their circular structure presents challenges for annotation and functional studies.
  • CircRNAs play roles in cancer development and may be targeted for therapy.

Conclusions:

  • CircRNAs hold significant potential as diagnostic and prognostic biomarkers for cancer.
  • Further research is needed to overcome challenges in circRNA detection and functional characterization.
  • CircRNAs represent a promising avenue for novel cancer-targeted therapies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K